A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype

Blood

Volumn 90, Issue 4, 1997, Pages 1552-1557

  Bernardi, F ^a   Faioni, E M ^b   Castoldi, E ^b   Lunghi, B ^b   Castaman, G ^b   Sacchi, E ^b   Mannucci, P M ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTEIN C;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE FREQUENCY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0030860494     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1552.1552_1552_1557     Document Type: Article

References (25)

1. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743, 1989
2. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
3. Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
4. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
5. Kalafatis M, Bertina RM, Rand MD, Mann KG: Characterization of the molecular defect in factor V R 506. J Biol Chem 270:4053, 1995
6. 506 to Gln mutation in the factor V gene. Biochem J 313:467, 1996
7. Dahlback B: Resistance to activated protein C, the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis. Thromb Haemost 73:739, 1995
8. Cox MJ, Rees DC, Martinson JJ, Clegg JB: Evidence for a single origin of factor V Leiden. Br J Haematol 92:1022, 1996
9. Greengard JS, Alhenc-Gelas M, Gandrille S, Emmerich J, Aiach M, Griffin J: Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor V deficiency associated with thrombosis. Thromb Haemost 73:1361, 1995 (abstr)
10. Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A: "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: Report of two cases belonging to two unrelated kindreds. Thromb Haemost 75:422, 1996
11. Shen NLL, Fan S, Pyati J, Graff R, LaPolla RJ, Edgington TS: The serine protease cofactor factor V is synthesized by lymphocytes. J Immunol 150:2992, 1993
12. Lunghi B, Iacoviello L, Gemmati D, DiIasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F: Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma. Thromb Haemost 75:45, 1996
13. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J: Modified test for activated protein C resistance. Lancet 344:1162, 1994
14. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846, 1987
15. Bayston TA, Ireland H, Olds RG, Thein SL, Lane DA: A polymorphism in the human coagulation factor V gene. Hum Mol Genet 3:2085, 1994
16. de Ronde H, Bertina RM: Laboratory diagnosis of APC resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 72:880, 1994
17. Castoldi E, Lunghi B, Mingozzi F, Ioannou P, Marchetti G, Bernardi F: New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V Leiden mutation in Mediterranean populations and Indians. Thromb Haemost (in press)
18. Terwilliger JD, Ott J: Handbook of Human Genetic Linkage. Baltimore, MD, Johns Hopkins, 1994
19. De Stefano V, Finazzi G, Mannucci PM: Inherited thrombophilia pathogenesis, clinical syndromes and management. Blood 87:3531, 1996
20. Odegaard B, Mann KG: Proteolysis of factor Va by factor X and activated protein C. J Biol Chem 262:11233, 1987
21. Rees DC: The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 95:579, 1996
22. Tishkoff SA, Dietzsch E, Speed W, Pakstis AJ, Kidd JR, Cheung K, Bonné-Tamir B, Santachiara-Benerecetti AS, Moral P, Krings M, Paabo S, Watson E, Risch N, Jenkins T, Kidd KK: Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 271:1380, 1996
23. Pittman DD, Tomkinson KN, Kaufman RJ: Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells. J Biol Chem 269:17329, 1994
24. Lu D, Kalafatis M, Mann KG, Long GL: Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 87:4708, 1996
25. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 346:1133, 1995